These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27442379)

  • 1. Generic Drugs - Decreasing Costs and Room for Increased Number of Kidney Transplantations.
    Spasovski G
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(2):133-8. PubMed ID: 27442379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generic immunosuppression in solid organ transplantation: a Canadian perspective.
    Harrison JJ; Schiff JR; Coursol CJ; Daley CJ; Dipchand AI; Heywood NM; Keough-Ryan TM; Keown PA; Levy GA; Lien DC; Wichart JR; Cantarovich M
    Transplantation; 2012 Apr; 93(7):657-65. PubMed ID: 22267158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Is the Future of Generics in Transplantation?
    van Gelder T
    Transplantation; 2015 Nov; 99(11):2269-73. PubMed ID: 26050017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.
    Alloway RR; Vinks AA; Fukuda T; Mizuno T; King EC; Zou Y; Jiang W; Woodle ES; Tremblay S; Klawitter J; Klawitter J; Christians U
    PLoS Med; 2017 Nov; 14(11):e1002428. PubMed ID: 29135993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is There Evidence to Support Brand to Generic Interchange of the Mycophenolic Acid Products?
    Phillips K; Reddy P; Gabardi S
    J Pharm Pract; 2017 Feb; 30(1):9-16. PubMed ID: 26043743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system.
    Spence MM; Nguyen LM; Hui RL; Chan J
    Pharmacotherapy; 2012 Nov; 32(11):981-7. PubMed ID: 23074134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic immunosuppression in transplantation: current evidence and controversial issues.
    El Hajj S; Kim M; Phillips K; Gabardi S
    Expert Rev Clin Immunol; 2015 May; 11(5):659-72. PubMed ID: 25817258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of Antibody-Based Induction Therapy in Deceased Donor Kidney Transplantation in the United States.
    Gharibi Z; Ayvaci MUS; Hahsler M; Giacoma T; Gaston RS; Tanriover B
    Transplantation; 2017 Jun; 101(6):1234-1241. PubMed ID: 27379555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generic immunosuppressants.
    Medeiros M; Lumini J; Stern N; Castañeda-Hernández G; Filler G
    Pediatr Nephrol; 2018 Jul; 33(7):1123-1131. PubMed ID: 28733752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Special considerations in generic substitution of immunosuppressive drugs in transplantation].
    Remport A; Dankó D; Gerlei Z; Czebe K; Kiss I
    Orv Hetil; 2012 Aug; 153(34):1341-9. PubMed ID: 22913916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generic tacrolimus in solid organ transplantation.
    Taube D; Jones G; O'Beirne J; Wennberg L; Connor A; Rasmussen A; Backman L
    Clin Transplant; 2014 May; 28(5):623-32. PubMed ID: 24750309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generics: are all immunosuppression agents created equally?
    Hauch A; John M; Smith A; Dortonne I; Patel U; Kandil E; Killackey M; Paramesh A; Lee B; Zhang R; Buell JF
    Surgery; 2015 Oct; 158(4):1049-54; discussion 1054-5. PubMed ID: 26206317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis.
    Molnar AO; Fergusson D; Tsampalieros AK; Bennett A; Fergusson N; Ramsay T; Knoll GA
    BMJ; 2015 Jun; 350():h3163. PubMed ID: 26101226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of ciclosporin (Equoral®) capsules after renal transplantation: A multicentre, open-label, phase IV clinical trial.
    Durlik M; Paczek L; Rutkowski B; Lewandowska D; Debska-Slizien A; Chamienia A; Wyzgal J; Ognista-Gajda A; Niemczyk M
    Ann Transplant; 2010; 15(3):51-9. PubMed ID: 20877267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Consensus statement of the Croatian Society for Nephrology, Dialysis and Transplantation regarding the use of generic immunosuppressive drugs].
    Bašić-Jukić N; Rački S; Knotek M; Bubić-Filipi L; Bubić I; Zibar L; Kes P;
    Acta Med Croatica; 2014 Apr; 68(2):211-4. PubMed ID: 26012162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secular Trends in the Cost of Immunosuppressants after Solid Organ Transplantation in the United States.
    Helmuth ME; Liu Q; Turenne MN; Park JM; Oguntimein M; Dutcher SK; Balkrishnan R; Sharma P; Zee J; Leichtman AB; Smith AR
    Clin J Am Soc Nephrol; 2019 Mar; 14(3):421-430. PubMed ID: 30819667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of generic cyclosporine arpimune in Filipino low-risk primary kidney transplant recipients.
    Pamugas GE; Danguilan RA; Lamban AB; Mangati VB; Ona ET
    Transplant Proc; 2012 Jan; 44(1):101-8. PubMed ID: 22310590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and Clinical Outcomes of Generic Tacrolimus (Hexal) Versus Branded Tacrolimus in De Novo Kidney Transplant Patients: A Multicenter, Randomized Trial.
    Arns W; Huppertz A; Rath T; Ziefle S; Rump LC; Hansen A; Budde K; Lehner LJ; Shipkova M; Baeumer D; Kroeger I; Sieder C; Klein T; Schenker P
    Transplantation; 2017 Nov; 101(11):2780-2788. PubMed ID: 28658202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic monitoring of pediatric renal transplant patients with conversion to generic cyclosporin.
    Riva N; Guido PC; Ibañez J; Licciardone N; Rousseau M; Mato G; Monteverde M; Schaiquevich P
    Int J Clin Pharm; 2014 Aug; 36(4):779-86. PubMed ID: 24861769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare costs in renal transplant recipients using branded versus generic ciclosporin.
    Helderman JH; Kang N; Legorreta AP; Chen JY
    Appl Health Econ Health Policy; 2010; 8(1):61-8. PubMed ID: 20038194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.